Is there a future for adoptive cell transfer in melanoma patients?

por Besser, Michal J
Publicado 2013

Focus on Adoptive T Cell Transfer Trials in Melanoma

por Hershkovitz, Liat, Schachter, Jacob, Treves, Avraham J., Besser, Michal J.
Publicado 2010

Modulating the proliferative and cytotoxic properties of patient-derived TIL by a synthetic immune niche of immobilized CCL21 and ICAM1

por Yunger, Sharon, Geiger, Benjamin, Friedman, Nir, Besser, Michal J., Adutler-Lieber, Shimrit
Publicado 2023

Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms

por Sapoznik, Sivan, Hammer, Ohad, Ortenberg, Rona, Besser, Michal J., Ben-Moshe, Tehila, Schachter, Jacob, Markel, Gal
Publicado 2012

Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction

por Weinstein-Marom, Hadas, Gross, Gideon, Levi, Michal, Brayer, Hadar, Schachter, Jacob, Itzhaki, Orit, Besser, Michal J.
Publicado 2021

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation

por Seliktar-Ofir, Sivan, Merhavi-Shoham, Efrat, Itzhaki, Orit, Yunger, Sharon, Markel, Gal, Schachter, Jacob, Besser, Michal J.
Publicado 2017

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia

por Rozenbaum, Meir, Meir, Amilia, Aharony, Yarden, Itzhaki, Orit, Schachter, Jacob, Bank, Ilan, Jacoby, Elad, Besser, Michal J.
Publicado 2020

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells()()

por Kfir-Elirachman, Karin, Ortenberg, Rona, Vizel, Bella, Besser, Michal J, Barshack, Iris, Schachter, Jacob, Nemlich, Yael, Markel, Gal
Publicado 2018

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex

por Greenberg, Eyal, Hajdu, Steven, Nemlich, Yael, Cohen, Ronit, Itzhaki, Orit, Jacob-Hirsch, Jasmine, Besser, Michal J., Schachter, Jacob, Markel, Gal
Publicado 2014

Impact of cryopreservation on CAR T production and clinical response

por Brezinger-Dayan, Karin, Itzhaki, Orit, Melnichenko, Jenny, Kubi, Adva, Zeltzer, Li-at, Jacoby, Elad, Avigdor, Abraham, Shapira Frommer, Ronnie, Besser, Michal J.
Publicado 2022

Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies

por Besser, Michal J., Shoham, Tsipi, Harari-Steinberg, Orit, Zabari, Naama, Ortenberg, Rona, Yakirevitch, Arkadi, Nagler, Arnon, Loewenthal, Ron, Schachter, Jacob, Markel, Gal
Publicado 2013

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma

por Galore-Haskel, Gilli, Baruch, Erez N., Berg, Amy L., Barshack, Iris, Zilinsky, Itzhak, Avivi, Camila, Besser, Michal J., Schachter, Jacob, Markel, Gal
Publicado 2017

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy

por Yunger, Sharon, Bar El, Assaf, Zeltzer, Li-at, Fridman, Eddie, Raviv, Gil, Laufer, Menachem, Schachter, Jacob, Markel, Gal, Itzhaki, Orit, Besser, Michal J
Publicado 2019

Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells

por Markel, Gal, Seidman, Rachel, Besser, Michal J., Zabari, Naama, Ortenberg, Rona, Shapira, Ronnie, Treves, Avraham J., Loewenthal, Ron, Orenstein, Arie, Nagler, Arnon, Schachter, Jacob
Publicado 2009

Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens

por Kalaora, Shelly, Barnea, Eilon, Merhavi-Shoham, Efrat, Qutob, Nouar, Teer, Jamie K., Shimony, Nilly, Schachter, Jacob, Rosenberg, Steven A., Besser, Michal J., Admon, Arie, Samuels, Yardena
Publicado 2016

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy

por Nissani, Abraham, Lev-Ari, Shaked, Meirson, Tomer, Jacoby, Elad, Asher, Nethanel, Ben-Betzalel, Guy, Itzhaki, Orit, Shapira-Frommer, Ronnie, Schachter, Jacob, Markel, Gal, Besser, Michal J.
Publicado 2021

Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy

por Blokon-Kogan, Dayana, Levi-Mann, Maya, Malka-Levy, Lior, Itzhaki, Orit, Besser, Michal J, Shiftan, Yuval, Szöőr, Árpád, Vereb, György, Gross, Gideon, Abken, Hinrich, Weinstein-Marom, Hadas
Publicado 2022

Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma

por Itzhaki, Orit, Greenberg, Eyal, Shalmon, Bruria, Kubi, Adva, Treves, Avraham J., Shapira-Frommer, Ronnie, Avivi, Camilla, Ortenberg, Rona, Ben-Ami, Eytan, Schachter, Jacob, Besser, Michal J., Markel, Gal
Publicado 2013

Regulation of Cancer Aggressive Features in Melanoma Cells by MicroRNAs

por Greenberg, Eyal, Hershkovitz, Liat, Itzhaki, Orit, Hajdu, Steven, Nemlich, Yael, Ortenberg, Rona, Gefen, Nir, Edry, Liat, Modai, Shira, Keisari, Yona, Besser, Michal J., Schachter, Jacob, Shomron, Noam, Markel, Gal
Publicado 2011

Predicting and controlling the reactivity of immune cell populations against cancer

por Oved, Kfir, Eden, Eran, Akerman, Martin, Noy, Roy, Wolchinsky, Ron, Izhaki, Orit, Schallmach, Ester, Kubi, Adva, Zabari, Naama, Schachter, Jacob, Alon, Uri, Mandel-Gutfreund, Yael, Besser, Michal J, Reiter, Yoram
Publicado 2009